8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Melatonin in pathogenesis and therapy of cancer

Bioeffects Seen

Authors not listed · 2006

Share:

EMF exposure may increase cancer risk by disrupting melatonin production, weakening natural immune defenses.

Plain English Summary

Summary written for general audiences

This 2006 review examined the 'melatonin hypothesis' of cancer, which proposes that exposure to artificial light at night and electromagnetic fields disrupts the body's natural melatonin production. The disruption of this sleep hormone may contribute to increased rates of breast cancer and childhood leukemia through weakened immune function and cellular repair mechanisms.

Why This Matters

This review crystallizes a critical mechanism by which EMF exposure may contribute to cancer development. The melatonin hypothesis provides a scientifically plausible pathway connecting our modern electromagnetic environment to rising cancer rates. Melatonin isn't just about sleep - it's a powerful antioxidant and immune system regulator that our bodies produce during darkness. When EMFs and artificial light disrupt this natural rhythm, we lose crucial nighttime cellular repair and immune surveillance. What makes this particularly concerning is the ubiquity of exposure. Every WiFi router, cell tower, and LED light in your bedroom potentially interferes with melatonin production. The science demonstrates that this isn't just about direct radiation damage to cells, but about disrupting fundamental biological processes that have evolved over millions of years to protect us from disease.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2006). Melatonin in pathogenesis and therapy of cancer.
Show BibTeX
@article{melatonin_in_pathogenesis_and_therapy_of_cancer_ce2206,
  author = {Unknown},
  title = {Melatonin in pathogenesis and therapy of cancer},
  year = {2006},
  doi = {10.4103/0019-5359.28983},
  
}
DOI: 10.4103/0019-5359.28983PubMed: 17130668

Quick Questions About This Study

The melatonin hypothesis proposes that exposure to artificial light at night and electromagnetic fields disrupts natural melatonin production, potentially increasing cancer risk by weakening immune function and cellular repair mechanisms that normally occur during sleep.
Research has particularly focused on breast cancer, childhood leukemia, melanoma, colon cancer, and lung cancer as potentially connected to melatonin disruption from light at night and EMF exposure, according to this scientific review.
Electromagnetic fields can interfere with the pineal gland's ability to produce melatonin, the hormone that regulates sleep-wake cycles and provides antioxidant protection. This disruption occurs even with low-level EMF exposure from common electronic devices.
Melatonin acts as a powerful antioxidant, free radical scavenger, and immune system modulator. It also has oncostatic properties, meaning it can help prevent tumor growth. Disrupted melatonin production weakens these natural cancer-fighting mechanisms.
Clinical studies show melatonin treatment in cancer patients resulted in substantial reduction in death risk with low adverse effects. However, maintaining natural melatonin production through reduced EMF exposure and proper sleep hygiene remains the optimal approach.